Anzeige
Mehr »
Login
Donnerstag, 14.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Kolumbiens nächster Kupferriese? Warum Investoren dieses 14.000-Meter-Bohrprogramm beobachten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
541 Leser
Artikel bewerten:
(2)

1812 Brewing Company Inc.: 1812 Brewing Company Wins "New York Amber Ale Brewery of the Year" Award at the 2023 New York International Beer Competition

Finanznachrichten News

-- KEGS' War of 1812 Amber Ale Wins Top Prize in the American Style Amber/Red Ale Category --

WATERTOWN, NY / ACCESSWIRE / April 18, 2023 / 1812 BREWING COMPANY, INC. (OTC PINK:KEGS) (the "Company" or "KEGS") is pleased to announce that the Company earned "2023 New York Amber Ale Brewery of the Year" award for its War of 1812 Amber Ale, which earned the top medal in its category in the 2023 New York International Beer Competition held in Rockefeller Center. This competition was open to all commercially produced beer, cider and mead from around the world. 1812 Brewing Company entered its War of 1812 Amber Ale in the "American Style Amber / Red Ale" category, where it was awarded the top medal in that category.

1812 Brewing Company Inc., Tuesday, April 18, 2023, Press release picture

"To have earned this award from the New York International Beer Competition is very exciting," stated Chairman and CEO Tom Scozzafava. "Not only is this validation of the quality of our 1812 Amber, but it further shows the product's potential in the marketplace. The fact that the competition is judged by actual beer buyers reflects that."

1812 Brewing Company recently announced that it has partnered with TapRm.com, a direct-to-consumer e-commerce and logistics company for distribution of War of 1812 Amber Ale that covers most areas of 45 states plus Washington DC. Customers can order the 1812 Amber Ale directly for shipment to your home or restaurant at:

https://1812-brewing.taprm.com/all-products

About the New York International Beer Competition:

The 2023 New York International Beer Competition had 700+ entries from over 15 countries competing in nearly 30 categories. The competition had the top beer buyers and trade professionals judging the products by their category and price point. This contest is the only international beer competition using the authorized categories of the United States Brewer Association (USABM) and where all the judges are real trade buyers who are judging the beer by category and actual price. These judges are buyers from the top New York Area liquor stores, restaurants, hotels and more.

About 1812 Brewing Company ("KEGS or the "Company"):

KEGS is an operator of and investor in companies in the craft beer industry. The Company seeks to build a nation-wide network of craft breweries to develop and foster respective brand growth at the local, regional, and national level. KEGS looks to build a network wherein certain economies of scale can be shared across it such as production, distribution footprint expansion, inter-member contract brewing, new product development, sharing of best brewery practices and scale logistics and transportation. The network is to be built through investment by 1812 Brewing Company while maintaining the members' respective local and regional uniqueness, brand autonomy and direct involvement with its consumers. The Company seeks to be an "incubator" of growth for its holdings in the industry.

The Company's current holding, 1812 Brewing Co., produces award-winning beers such as War of 1812 Amber Ale ("1812 Amber Ale"), 1812 Light, Hazy Oasis Pale Ale, Thousand Islands IPA, Malicious Intent XX IPA, Route 11 Lager, Railroad Red Ale, Helles Bells Pilsner, St. Stephens Stout, Third Rail Porter, Featherhammer Maibock.

For more updates follow us on our Website, Facebook, Twitter, Instagram and Linkedin.

https://www.kegsnetwork.com/
https://www.facebook.com/kegsnetwork/
https://www.instagram.com/kegsnetwork/
https://twitter.com/kegsnetwork

https://www.1812ale.com/
https://www.facebook.com/1812brewingcompany/
https://www.instagram.com/1812brewingcompany/
https://twitter.com/1812Brewing
https://www.linkedin.com/company/1812brewingcompany/

Contact:

Contact Name: Tom Scozzafava
Contact Phone Number: 315-788-1812
Contact Email Address: contact@1812ale.com

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

SOURCE: 1812 Brewing Company Inc.

View source version on accesswire.com:
https://www.accesswire.com/749774/1812-Brewing-Company-Wins-New-York-Amber-Ale-Brewery-of-the-Year-Award-at-the-2023-New-York-International-Beer-Competition

© 2023 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.